Skip to main content
MBX
NASDAQ Life Sciences

Q3 Loss Widens to $62.4M on Former-CEO Stock Comp; $481.6M Cash Funds Runway Into 2029

Tom Rudovsky · Reported by GlobeNewswire
More coverage: Biotech Stocks · Healthcare
Sentiment info
Neutral
Importance info
7
Price
$53.31
Mkt Cap
$2.604B
52W Low
$21.9
52W High
$72.64
52W Position info
143% above low
Off High info
27% below high
Rel. Volume info
1.3× avg
Market data snapshot near publication time

MBX has more than doubled off its 52-week low of $21.9.

Summary

MBX posted a $62.4M Q3 net loss versus $21.6M a year ago, but $20.8M of that gap is a one-time stock-comp modification for the former CEO that pushed G&A to $34.3M from $4.7M. R&D rose to $32.0M from $19.3M as the canvuparatide Phase 3 oPTimize trial started up. Cash and investments stand at $481.6M after $97.6M of net ATM proceeds, enough to fund operations into 2029 — no near-term financing need. The operational news is the timeline: first patient dosed in the pivotal Phase 3 in August, and unblinded 12-week MAD data for once-monthly obesity candidate MBX 4291 still on track for Q4 2026. Preclinical MBX 6180 data will be presented at ObesityWeek, November 14-17, 2026.

At the time of this announcement, MBX was trading at $53.31 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $2.6B. The 52-week trading range was $21.90 to $72.64. This news item was assessed with neutral market sentiment and an importance score of 7 out of 10. Source: GlobeNewswire.


Price Chart

Share this article

Copied!

MBX - Latest Insights

MBX
Nov 09, 2026, 4:05 PM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $53.31
Real-time Price: $54.47 info
Change: +$1.16 (+2%) info
Market Cap: $2.705B info
MBX
Aug 27, 2026, 8:00 AM EDT
Source: GlobeNewswire
Importance Score:
8
Price at Filing: $66.50
Real-time Price: $54.47 info
Change: -$12.03 (-18%) info
Market Cap: $2.705B info
MBX
Aug 10, 2026, 4:44 PM EDT
Filing Type: SCHEDULE 13D/A
Importance Score:
7
Price at Filing: $66.15
Real-time Price: $54.47 info
Change: -$11.68 (-18%) info
Market Cap: $2.705B info
MBX
Aug 06, 2026, 8:06 AM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $67.80
Real-time Price: $54.47 info
Change: -$13.33 (-20%) info
Market Cap: $2.705B info
MBX
Aug 06, 2026, 8:03 AM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $67.80
Real-time Price: $54.47 info
Change: -$13.33 (-20%) info
Market Cap: $2.705B info